Irish man injects own semen into arm to cure 'back pain'


The man, who had been suffering from regular bouts of backache throughout is life, made a decision to take matters into his own hands, purchased a hypodermic needle online and started injecting himself with his own semen.

The 33-year-old man developed a cure for his chronic back pain.

She added that he had "failed multiple attempts at injecting the bodily fluid", in what she described as an "innovative method to treat back pain".

The man injected himself "independent of medical advice". He had been injecting himself with an undisclosed dose of semen once a month, for at least 18 months. It seems that the semen had started pooling and clotting under the skin, creating a bacterial infection of the skin called cellulitis. However, medics noticed a red rash and swelling in his forearm.

But he'd only come into the emergency room when his back pain worsened after attempting to lift a heavy steel object. He refused to seek professional medical help at Adelaide and Meath Hospital and left before doctors could remove semen from his arm.

This patient's back pain improved over the course of his hospital stay and he opted to discharge himself without availing of an incision and drainage of the "local collection".

An x-ray of the mans arm.

The Irish Medical Journal noted the only past examples of semen injection occurred in 1945 when human ejaculate was injected into female rats and rabbits.

The only other medical study involving sperm injections took place in 1945, by scientists at the University of Glasgow. "A search of more eclectic internet sites and forums found no other documentation of semen injection for back pain treatment or other uses".

Still, the case is educational, even for those who do not plan on injecting themselves with semen (and please, do not plan on doing this): The case highlights the dangers of intravenous injections when carried out by untrained individuals, as well as the risks surrounding the attempted injections of substances not intended for intravenous use, the authors wrote.